Dopamine D3 receptors regulate GABAA receptor function through a phospho-dependent endocytosis mechanism in nucleus accumbens

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Guojun ChenZhen Yan

Abstract

The dopamine D3 receptor, which is highly enriched in nucleus accumbens (NAc), has been suggested to play an important role in reinforcement and reward. To understand the potential cellular mechanism underlying D3 receptor functions, we examined the effect of D3 receptor activation on GABAA receptor (GABAAR)-mediated current and inhibitory synaptic transmission in medium spiny neurons of NAc. Application of PD128907 [(4aR,10bR)-3,4a,4,10b-tetrahydro-4-propyl-2H,5H-[1]benzopyrano-[4,3-b]-1,4-oxazin-9-ol hydrochloride], a specific D3 receptor agonist, caused a significant reduction of GABAAR current in acutely dissociated NAc neurons and miniature IPSC amplitude in NAc slices. This effect was blocked by dialysis with a dynamin inhibitory peptide, which prevents the clathrin/activator protein 2 (AP2)-mediated GABAA receptor endocytosis. In addition, the D3 effect on GABAAR current was prevented by agents that manipulate protein kinase A (PKA) activity. Infusion of a peptide derived from GABAAR beta subunits, which contains an atypical binding motif for the clathrin AP2 adaptor complex and the major PKA phosphorylation sites and binds with high affinity to AP2 only when dephosphorylated, diminished the D3 regulation of IPSC amplitu...Continue Reading

Citations

Jan 29, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Marvin R DiazBrian A McCool
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Colin M StopperStan B Floresco
Apr 3, 2008·Nature Reviews. Neuroscience·Tija C JacobRachel Jurd
Feb 29, 2008·Proceedings of the National Academy of Sciences of the United States of America·Josef T KittlerStephen J Moss
Oct 10, 2009·Proceedings of the National Academy of Sciences of the United States of America·I Lorena Arancibia-CárcamoStephen J Moss
Jan 31, 2009·The Journal of Biological Chemistry·Nicholas M GrazianeZhen Yan
Jan 11, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Miho TerunumaStephen J Moss
Apr 24, 2009·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Megan J JanssenStefano Vicini
Mar 14, 2014·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Erin N BobeckSusan L Ingram
Feb 26, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Darren GoffinJasmina N Jovanovic
Sep 27, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Mansi VithlaniStephen J Moss
Sep 16, 2009·The Journal of Physiology·Shiva K Tyagarajan, Jean-Marc Fritschy
Jul 24, 2010·Current Opinion in Neurobiology·Katharine R Smith, Josef T Kittler
Jan 1, 2010·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Jan J Braszko
Aug 25, 2007·Progress in Neuro-psychopharmacology & Biological Psychiatry·Qian BianShigenobu Kanba
Jun 10, 2011·Synapse·Miguel Ángel Velázquez-Flores, Rocío Salceda
Mar 22, 2016·Expert Reviews in Molecular Medicine·Wei WangJing Luo
Jun 21, 2015·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Melissa J S CheeEleftheria Maratos-Flier
Dec 9, 2014·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Gian Marco LeggioSalvatore Salomone
Jul 19, 2014·Molecular Neurobiology·Liang WangXuefeng Wang
Jun 26, 2007·Developmental Biology·Anita HsounaJanis M O'Donnell
Oct 13, 2012·Journal of Pharmacological Sciences·Hiroko IkedaAlexander R Cools
Sep 1, 2017·Journal of Central Nervous System Disease·G Aleph Prieto
Aug 13, 2013·The Journal of Biological Chemistry·Severine ChaumontMaurice Garret
Nov 16, 2019·CNS Neuroscience & Therapeutics·Xi LuXue-Feng Wang
Jan 29, 2014·Reviews in the Neurosciences·Vincenzo Crunelli, Giuseppe Di Giovanni
Sep 13, 2019·The Journal of Pharmacology and Experimental Therapeutics·Mei HuangHerbert Y Meltzer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.